Literature DB >> 25220265

Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPV-induced vulvar neoplasia.

Edith M G van Esch1, Mariette I E van Poelgeest, J Baptist M Z Trimbos, Gert Jan Fleuren, Ekaterina S Jordanova, Sjoerd H van der Burg.   

Abstract

Human papilloma virus (HPV)-induced usual-type vulvar intraepithelial neoplasia (uVIN) is infiltrated by myeloid cells but the type and role of these cells is unclear. We used triple immunofluorescent confocal microscopy to locate, identify and quantify myeloid cells based on their staining pattern for CD14, CD33 and CD163 in a cohort of 43 primary and 20 recurrent uVIN lesions, 21 carcinomas and 26 normal vulvar tissues. The progressive course of uVIN is characterized by an increase in both intraepithelial and stromal mature M1 and M2 macrophages. While the M2 macrophages outnumber M1 macrophages in healthy controls and uVIN, they are matched in number by M1 macrophages in cancer. Importantly, uVIN patients with a dense intraepithelial infiltration with mature CD14+ macrophages (irrespective of M1 or M2 type) displayed approximately a six times higher risk to develop a recurrence and a high number of these cells constituted an independent prognostic factor for recurrence. In addition, a dense intraepithelial CD14+ cell infiltration was associated with high numbers of intraepithelial CD4+ Tregs and low numbers of stromal CD8+TIM3+ T cells. Patients with low numbers of intraepithelial CD14+ cells and high numbers of stromal CD8+TIM3+ cells showed the best recurrence-free survival. These data clearly show the importance of the local immune response in HPV-induced vulvar neoplasia and may be of help in predicting the prognosis of patients or their response to immunotherapy.
© 2014 UICC.

Entities:  

Keywords:  CD14; HPV; macrophages; usual VIN; vulvar carcinoma

Mesh:

Year:  2014        PMID: 25220265     DOI: 10.1002/ijc.29173

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  [Tumor-associated macrophages: Function and differentiation].

Authors:  G Niedobitek; M H Barros; J H Dreyer; F Hauck; D Al-Sheikhyaqoob
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

Review 2.  Opportunities and challenges for human papillomavirus vaccination in cancer.

Authors:  Richard B S Roden; Peter L Stern
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 3.  Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy.

Authors:  Sigrun Smola; Connie Trimble; Peter L Stern
Journal:  Ther Adv Vaccines       Date:  2017-07-05

4.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

5.  Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients.

Authors:  Sonia Furgiuele; Géraldine Descamps; Jerome R Lechien; Didier Dequanter; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

6.  Correlation of Circulating CD64+/CD163+ Monocyte Ratio and stroma/peri-tumoral CD163+ Monocyte Density with Human Papillomavirus Infected Cervical Lesion Severity.

Authors:  Piyawut Swangphon; Chamsai Pientong; Nuchsupha Sunthamala; Sureewan Bumrungthai; Miyuki Azuma; Pilaiwan Kleebkaow; Thumwadee Tangsiriwatthana; Ussanee Sangkomkamhang; Bunkerd Kongyingyoes; Tipaya Ekalaksananan
Journal:  Cancer Microenviron       Date:  2017-10-24

Review 7.  Tumour virus vaccines: hepatitis B virus and human papillomavirus.

Authors:  Margaret Stanley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 8.  Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Authors:  Theresa A Lawrie; Andy Nordin; Manas Chakrabarti; Andrew Bryant; Sonali Kaushik; Litha Pepas
Journal:  Cochrane Database Syst Rev       Date:  2016-01-05

9.  T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.

Authors:  Andrew W Woodham; Lisa Yan; Joseph G Skeate; Daniel van der Veen; Heike H Brand; Michael K Wong; Diane M Da Silva; W Martin Kast
Journal:  Papillomavirus Res       Date:  2016-12

Review 10.  Medical interventions for high-grade vulval intraepithelial neoplasia.

Authors:  Litha Pepas; Sonali Kaushik; Andy Nordin; Andrew Bryant; Theresa A Lawrie
Journal:  Cochrane Database Syst Rev       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.